BDM inhibition of cardiac mitochondrial respiration

Russell Scaduto, L. W. Grotyohann

Research output: Contribution to journalArticle

Abstract

BDM (Butanedione monoxime) was used to suppress work output by the Langendorff perfused rat heart. Hearts were perfused with buffer containing BDM and elevated concentrations of perfusate calcium (BDM plus Ca2+) in order to maintain rates of cardiac work and oxygen consumption at levels identical to hearts perfused with a normal calcium concentration (control). BDM plus Ca2+ hearts displayed higher levels of NADH surface fluorescence, indicating an activating effect of calcium on mitochondrial enzymes. BDM plus Ca2+ hearts, however, displayed 20% lower tissue levels of phosphocreatine (PCr). Isolated mitochondria were incubated with BDM to study this effect. BDM suppressed rates of State 3 respiration. Fifty percent inhibition occurred with 5 mM BDM. Uncoupled and State 4 respiration rates were not affected. Similar results were obtained with mitochondria from liver. Steady state levels of mitochondrial NADH were not affected at any respiration rate. Double inhibitor experiments with BDM and carboxyatractyloside (CAT) were performed to identify the site of BDM inhibition. Low levels of BDM (0 to 5 mM) suppressed respiration in a near linear fashion. In the presence of CAT, at levels which inhibit respiration by 60%, low levels of BDM were without effect. The fact the effects of BDM and CAT were not additive indicates that BDM does not inhibit adenine nucleotide transport. These data indicate that BDM inhibits oxidative phosphorylation at a site on the mitochondrial ATPase.

Original languageEnglish (US)
JournalFASEB Journal
Volume12
Issue number5
StatePublished - Mar 20 1998

Fingerprint

Respiration
Mitochondria
diacetylmonoxime
Respiratory Rate
Calcium
NAD
Phosphocreatine
Adenine Nucleotides
Liver Mitochondrion
Oxidative Phosphorylation
Oxygen Consumption
Liver
Adenosine Triphosphatases
Rats
Buffers
Fluorescence
Tissue
Oxygen

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Biochemistry
  • Molecular Biology
  • Genetics

Cite this

Scaduto, R., & Grotyohann, L. W. (1998). BDM inhibition of cardiac mitochondrial respiration. FASEB Journal, 12(5).
Scaduto, Russell ; Grotyohann, L. W. / BDM inhibition of cardiac mitochondrial respiration. In: FASEB Journal. 1998 ; Vol. 12, No. 5.
@article{d7e4d24a1b56430abce186ea4d1a4a7a,
title = "BDM inhibition of cardiac mitochondrial respiration",
abstract = "BDM (Butanedione monoxime) was used to suppress work output by the Langendorff perfused rat heart. Hearts were perfused with buffer containing BDM and elevated concentrations of perfusate calcium (BDM plus Ca2+) in order to maintain rates of cardiac work and oxygen consumption at levels identical to hearts perfused with a normal calcium concentration (control). BDM plus Ca2+ hearts displayed higher levels of NADH surface fluorescence, indicating an activating effect of calcium on mitochondrial enzymes. BDM plus Ca2+ hearts, however, displayed 20{\%} lower tissue levels of phosphocreatine (PCr). Isolated mitochondria were incubated with BDM to study this effect. BDM suppressed rates of State 3 respiration. Fifty percent inhibition occurred with 5 mM BDM. Uncoupled and State 4 respiration rates were not affected. Similar results were obtained with mitochondria from liver. Steady state levels of mitochondrial NADH were not affected at any respiration rate. Double inhibitor experiments with BDM and carboxyatractyloside (CAT) were performed to identify the site of BDM inhibition. Low levels of BDM (0 to 5 mM) suppressed respiration in a near linear fashion. In the presence of CAT, at levels which inhibit respiration by 60{\%}, low levels of BDM were without effect. The fact the effects of BDM and CAT were not additive indicates that BDM does not inhibit adenine nucleotide transport. These data indicate that BDM inhibits oxidative phosphorylation at a site on the mitochondrial ATPase.",
author = "Russell Scaduto and Grotyohann, {L. W.}",
year = "1998",
month = "3",
day = "20",
language = "English (US)",
volume = "12",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "5",

}

Scaduto, R & Grotyohann, LW 1998, 'BDM inhibition of cardiac mitochondrial respiration', FASEB Journal, vol. 12, no. 5.

BDM inhibition of cardiac mitochondrial respiration. / Scaduto, Russell; Grotyohann, L. W.

In: FASEB Journal, Vol. 12, No. 5, 20.03.1998.

Research output: Contribution to journalArticle

TY - JOUR

T1 - BDM inhibition of cardiac mitochondrial respiration

AU - Scaduto, Russell

AU - Grotyohann, L. W.

PY - 1998/3/20

Y1 - 1998/3/20

N2 - BDM (Butanedione monoxime) was used to suppress work output by the Langendorff perfused rat heart. Hearts were perfused with buffer containing BDM and elevated concentrations of perfusate calcium (BDM plus Ca2+) in order to maintain rates of cardiac work and oxygen consumption at levels identical to hearts perfused with a normal calcium concentration (control). BDM plus Ca2+ hearts displayed higher levels of NADH surface fluorescence, indicating an activating effect of calcium on mitochondrial enzymes. BDM plus Ca2+ hearts, however, displayed 20% lower tissue levels of phosphocreatine (PCr). Isolated mitochondria were incubated with BDM to study this effect. BDM suppressed rates of State 3 respiration. Fifty percent inhibition occurred with 5 mM BDM. Uncoupled and State 4 respiration rates were not affected. Similar results were obtained with mitochondria from liver. Steady state levels of mitochondrial NADH were not affected at any respiration rate. Double inhibitor experiments with BDM and carboxyatractyloside (CAT) were performed to identify the site of BDM inhibition. Low levels of BDM (0 to 5 mM) suppressed respiration in a near linear fashion. In the presence of CAT, at levels which inhibit respiration by 60%, low levels of BDM were without effect. The fact the effects of BDM and CAT were not additive indicates that BDM does not inhibit adenine nucleotide transport. These data indicate that BDM inhibits oxidative phosphorylation at a site on the mitochondrial ATPase.

AB - BDM (Butanedione monoxime) was used to suppress work output by the Langendorff perfused rat heart. Hearts were perfused with buffer containing BDM and elevated concentrations of perfusate calcium (BDM plus Ca2+) in order to maintain rates of cardiac work and oxygen consumption at levels identical to hearts perfused with a normal calcium concentration (control). BDM plus Ca2+ hearts displayed higher levels of NADH surface fluorescence, indicating an activating effect of calcium on mitochondrial enzymes. BDM plus Ca2+ hearts, however, displayed 20% lower tissue levels of phosphocreatine (PCr). Isolated mitochondria were incubated with BDM to study this effect. BDM suppressed rates of State 3 respiration. Fifty percent inhibition occurred with 5 mM BDM. Uncoupled and State 4 respiration rates were not affected. Similar results were obtained with mitochondria from liver. Steady state levels of mitochondrial NADH were not affected at any respiration rate. Double inhibitor experiments with BDM and carboxyatractyloside (CAT) were performed to identify the site of BDM inhibition. Low levels of BDM (0 to 5 mM) suppressed respiration in a near linear fashion. In the presence of CAT, at levels which inhibit respiration by 60%, low levels of BDM were without effect. The fact the effects of BDM and CAT were not additive indicates that BDM does not inhibit adenine nucleotide transport. These data indicate that BDM inhibits oxidative phosphorylation at a site on the mitochondrial ATPase.

UR - http://www.scopus.com/inward/record.url?scp=33749333754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749333754&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33749333754

VL - 12

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 5

ER -

Scaduto R, Grotyohann LW. BDM inhibition of cardiac mitochondrial respiration. FASEB Journal. 1998 Mar 20;12(5).